RxDoctor Payments Data

Franklin Zieve

Internal Medicine · Richmond, VANPI 1538195060

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $823 of the $1,174 with a category attached, or 70.1%. Novo Nordisk AS accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest.

$1,174in general payments, 2019–2025

Across 5 payments — averaging $234.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1K
  • Travere Therapeutics, Inc.$1
$338,542in research payments, 2019–2025

Across 158 payments — averaging $2142.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kowa Research Institute, Inc.$152K
  • Sanofi US Services Inc.$132K
  • Novo Nordisk AS$28K
  • AstraZeneca$15K
  • Eli Lilly$6K
  • Lexicon Pharmaceuticals, Inc.$3K
  • plus $3K from 3 others

What the payments were for

  • Travel & lodging$82370%
  • Food & beverage$35030%
  • Education$10%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS4$1,173
Travere Therapeutics, Inc.1$1

How this compares

$1,174 in reported general payments places this provider in the 80th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia →

Other internal medicine in Richmond

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →